Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
European Journal of Internal Medicine|January 20, 2017
COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitisKalliopi Zachou, Stella Gabeta, Zakera Shums, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 15, 2018
Successful pregnancy outcomes following liver transplantation is predicted by renal functionTiong Y Lim, Enoka Gonsalkorala, Mary D Cannon, et al.Autoimmunity|June 20, 2013
Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the diseaseNikolaos K Gatselis, Kalliopi Zachou, Gary L Norman, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 20, 2010
Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score?Nikolaos K Gatselis, Kalliopi Zachou, Panagiotis Papamichalis, et al.Frontiers in Immunology|January 28, 2022
First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH PatientsGeorge N Dalekos, Pinelopi Arvaniti, Nikolaos K Gatselis, et al.World Journal of Hepatology|July 31, 2013
Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threatKalliopi Zachou, Alexandros Sarantopoulos, Nikolaos K Gatselis, et al.Journal of Clinical Immunology|May 22, 2007
Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosisStella Gabeta, Gary L Norman, Christos Liaskos, et al.JHEP Reports : Innovation in Hepatology|November 22, 2022
Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitisGeorge N Dalekos, Pinelopi Arvaniti, Nikolaos K Gatselis, et al.Annals of Gastroenterology|November 29, 2023
FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver diseasePinelopi Arvaniti, George Giannoulis, Vasiliki Lygoura, et al.European Journal of Gastroenterology & Hepatology|March 3, 2020
Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centersMaria Tampaki, Nikolaos K Gatselis, Spyridon Savvanis, et al.Pageof 4